Receptivity to misinformation is associated with a preference for complementary alternative medicine for atopic dermatitis

Documenti analoghi

• Response to upadacitinib in a patient with atopic dermatitis and HIV
  di: Constanza Riquelme‐Mc Loughlin, et al.
  Pubblicazione: (2024)
• Generational differences in perceived severity of atopic dermatitis
  di: Clara Ureña‐Paniego, et al.
  Pubblicazione: (2024)
• Abrocitinib: a useful treatment option for CARD14‐mutation‐associated atopic dermatitis
  di: Fengjie Liu, et al.
  Pubblicazione: (2024)
• Molluscum contagiosum under treatment with upadacitinib for atopic dermatitis
  di: Cristina Bertoli, et al.
  Pubblicazione: (2024)
• Two‐sample Mendelian randomization analysis identifies a causal association between atopic dermatitis and impetigo
  di: Michael J. Diaz, et al.
  Pubblicazione: (2024)